Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer

Xue-Qing Hu; Yang Sun; Eric Lau; Ming Zhao; Shi-Bing Su

doi:10.2174/1568009616666151207105851

ISSN: 1568-0096
E-ISSN: 1873-5576

s Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer
By Xue-Qing Hu, Yang Sun, Eric Lau, Ming Zhao and Shi-Bing Su
Source: Current Cancer Drug Targets, Volume 16, Issue 4, May 2016, p. 346 - 356
DOI: https://doi.org/10.2174/1568009616666151207105851
- Available online: 01 May 2016

Abstract

The complex pathology of cancer development requires correspondingly complex treatments. The traditional application of individual single-target drugs fails to sufficiently treat cancer with durable therapeutic effects and tolerable adverse events. Therefore, synergistic combinations of drugs represent a promising way to enhance efficacy, overcome toxicity and optimize safety. Chinese Herbal Medicines (CHMs) have long been used as such synergistic combinations. Therefore, we summarized the synergistic combinations of CHMs used in the treatment of cancer and their roles in chemotherapy in terms of enhancing efficacy, reducing side effects, immune modulation, as well as abrogating drug resistance. Our conclusions support the development of further science-based holistic modalities for cancer care.

Article metrics loading...

/content/journals/ccdt/10.2174/1568009616666151207105851

2016-05-01

2025-09-16

From This Site

/content/journals/ccdt/10.2174/1568009616666151207105851

dcterms_title,dcterms_subject,pub_keyword

-contentType:Contributor -contentType:Concept -contentType:Institution

10

5

Full text loading...

/content/journals/ccdt/10.2174/1568009616666151207105851

Article Type: Research Article

Keyword(s): Cancer treatment; Chinese medicine; drug resistance; effect; immunity; side effects; synergistic combination

Most Cited Most Cited RSS feed

- Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy
  
  Authors: Yong Lin, Ranxin Shi, Xia Wang and Han-Ming Shen
- The Role of Snail in EMT and Tumorigenesis
  
  Authors: Yifan Wang, Jian Shi, Kequn Chai, Xuhua Ying and Binhua P. Zhou
- The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications
  
  Authors: Amancio Carnero, Carmen Blanco-Aparicio, Oliver Renner, Wolfgang Link and Juan F.M. Leal
- Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
  
  Authors: D. Chen, M. Frezza, S. Schmitt, J. Kanwar and Q. P. Dou
- P-glycoprotein Inhibition as a Therapeutic Approach for Overcoming Multidrug Resistance in Cancer: Current Status and Future Perspectives
  
  Authors: Ziyad Binkhathlan and Afsaneh Lavasanifar
- Taxanes: Microtubule and Centrosome Targets, and Cell Cycle Dependent Mechanisms of Action
  
  Authors: M. Abal, J.M. Andreu and I. Barasoain
- Paclitaxel Resistance: Molecular Mechanisms and Pharmacologic Manipulation
  
  Authors: R.Z. Yusuf, Z. Duan, D.E. Lamendola, R.T. Penson and M.V. Seiden
- The Role of Fibroblast Growth Factors in Tumor Growth
  
  Authors: M. Korc and R. E. Friesel
- Garlic [Allium sativum]: A Review of its Potential Use as an Anti-Cancer Agent
  
  Authors: M. Thomson and M. Ali
- Oxidative Stress and Cancer: The Role of Nrf2
  
  Authors: Soraya Sajadimajd and Mozafar Khazaei
More Less

s Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer

Abstract

Most Read This Month

Most Cited Most Cited RSS feed